Cabaletta Bio announced the final results from the exercise of its common stock warrants, which expired on September 12, 2026. The warrants, originally issued in a June 2025 public offering, generated significant capital for the company.
Key Details
- Total Proceeds: The company received aggregate gross proceeds of approximately $128.2 million from the exercise of all warrants from issuance through the expiration date.
- Recent Activity: From July 1, 2026, through the expiration date, the exercise of 46,011,900 warrants resulted in gross proceeds of approximately $115.0 million.
- Warrant Terms: The warrants had an exercise price of $2.50 per share and an expiration date of September 12, 2026.